EOFlow Submits Application to the U.S. FDA for its Wearable Insulin Pump ‘EOPatch’

Plans to finalize its U.S. distribution strategy in 2023 Aims to enter the U.S., the world's largest diabetes market, with its current disposable wearable insulin pump 'EOPatch' SAN JOSE, Calif. , Dec. 27, 2022 /PRNewswire/ -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a...

Click to view original post